Cardiovascular complications of COVID-19 risk, pathogenesis and outcomes Umair Mallick.

Includes bibliographies and index.

The Epidemiology of CoViD19 and Cardiovascular Diseases

Epidemiology -- Discussion

Virology of CoViD19

Viral Characteristics -- Mechanism of Viral Entry in Cells

An Introduction to the Clinical and Diagnostic Features, and CoViD19 Complications

Clinical Symptomatology -- Sepsis and Complications of CoViD19 -- Important Diagnostic Features

The Pathological Features of CoViD19 Cardiovascular Complications

Key Features of Cardiovascular Pathology

Treatment Options in CoViDI9

Antiviral Agents in CoViD19 -- Amino Quinolones in CoViD19 -- Immune-Based Therapies in CoViD19 -- Potential Anti-inflammatory Mechanisms -- Anticoagulants -- CoViD19 Vaccines

An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications

Acute Pulmonary Injury -- Sepsis and Multi-organ Failure -- Renin Angiotensin System -- Endothelin System -- Immune-Inflammation

Overview of Cytokines and CoViD19

Cytokines -- Cytokine Storm in CoViD19 -- Cytokines in Cardiovascular and Metabolic Diseases

The Renin-Angiotensin System in CoViD19

The Renin Angiotensin System -- The Dynamics of ACE2 Expression in CoViD19 -- ACE2 is a Marker of Severity or a Compensatory Mechanism?

Thrombosis in CoViD19

Mechanisms Promoting Thrombosis in CoViD19

Pathogenesis of CoViD19- Miscellaneous Mechanisms

Regulatory Peptide Systems in CoViD19 -- Miscellaneous Mechanisms

Myocardial Injury in CoViD19

Epidemiology of Myocardial Injury -- Definition, Presentation, and Challenges of Myocardial Injury -- Timing and Assessment of Myocardial Injury -- Biomarkers of Myocardial Injury -- Pathogenesis of the Myocardial Injury

Heart Failure in CoViD19

Epidemiology -- Role of Comorbidities in Heart Failure with CoViD19 -- Biomarkers of Heart Failure in CoViD19 -- Pathogenetic Mechanisms of Heart Failure in CoViD19

Hypertension in CoViD19

Epidemiology -- Complexities in Hypertension and CoViD19 -- CoViD19 Susceptibility and Hypertension -- Pathogenesis

Cardiac Arrhythmias in CoViD19

Epidemiology of Arrhythmias in CoViD19 -- Pathogenesis of Arrhythmias in CoViD19

Acute Coronary Syndromes in CoViD19

Epidemiology of Acute Coronary Syndromes in CoViD19 -- Defining Acute Coronary Syndromes, Challenges in Presentation and Assessment -- Pathogenesis of Acute Coronary Syndromes in CoViD19

Diabetes Mellitus and COVID19

Epidemiology -- Pathogenesis -- Treatment Implications

Obesity and COVID19

Pathogenetic Links - Obesity and CoViD19

The Older Age Adults and CoViD19 -- Epidemiology

Gender Disparity in CoViD19

Epidemiology -- Discrepancies in the Epidemiological Data -- Factors Associated with Gender Dichotomy -- Gender Disparity in Immune Response -- Gender Disparity in ACE2 Mechanisms -- Gender Disparity in Cardiovascular Diseases

An Overview of Quality of Research in CoViD19

Quality Issues in CoViD19 Research and Improvement Initiatives.

"Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19."

COPYRIGHT NOT covered - Click this link to request copyright permission:

https://lib.ciu.edu/copyright-request-form